# Reproductive Medicine Institute – FDA Inspection, Jan 13, 2016

Source: https://www.keypedia.com/records/fda_inspections/reproductive-medicine-institute/326e27a8-1aa1-4cb2-aa9e-41ea5e8e2ae2
Source feed: FDA_Inspections

> FDA inspection 960979 of Reproductive Medicine Institute, January 13, 2016. Classification: No Action Indicated (NAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 960979
- Company Name: Reproductive Medicine Institute
- Inspection Date: 2016-01-13
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1122259 - 2020-02-05
- FDA Inspection 1045293 - 2018-02-08
- [FDA Inspection 813531 - 2013-01-18](https://www.keypedia.com/records/fda_inspections/reproductive-medicine-institute/e4cff895-8efb-443e-8118-7bcc26d0e2ea)

Company: https://www.keypedia.com/companies/reproductive-medicine-institute/3f437b59-fb18-438b-bb0a-9e2c5d275c06

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d